Form 8-K - Current report:
SEC Accession No. 0000950123-10-077313
Filing Date
2010-08-13
Accepted
2010-08-13 16:09:40
Documents
6
Period of Report
2010-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v56683e8vk.htm 8-K 42317
2 EXHIBIT 2.1 v56683exv2w1.htm EX-2.1 399721
3 EX-10.1 v56683exv10w1.htm EX-10.1 89962
4 EX-10.2 v56683exv10w2.htm EX-10.2 67755
5 EX-10.3 v56683exv10w3.htm EX-10.3 29162
6 EX-10.4 v56683exv10w4.htm EX-10.4 30929
  Complete submission text file 0000950123-10-077313.txt   661385
Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 2068380500
Trubion Pharmaceuticals, Inc (Filer) CIK: 0001298521 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33054 | Film No.: 101015469
SIC: 2834 Pharmaceutical Preparations